Integral Health Asset Management’s Arrowhead Research ARWR Stock Holding History

Integral Health Asset Management’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.8M	Buy	300,000 +200,000	+200%	+$12.7M	0.9%	28
2025 Q4	$6.64M	Sell	100,000 -125,000	-56%	-$6.13M	0.33%	66
2025 Q3	$7.76M	Buy	+225,000	New	+$4.95M	0.53%	60
2025 Q2	–	Sell	-175,000	Closed	-$2.23M	–	74
2025 Q1	$2.23M	Sell	175,000 -100,000	-36%	-$1.82M	0.24%	72
2024 Q4	$5.17M	Buy	+275,000	New	+$5.66M	0.44%	63
2022 Q1	–	Sell	-50,000	Closed	-$3.31M	–	76
2021 Q4	$3.31M	Buy	+50,000	New	+$3.44M	0.92%	36
2021 Q1	–	Sell	-50,000	Closed	-$3.84M	–	72
2020 Q4	$3.84M	Buy	+50,000	New	+$3.2M	1.14%	32

Other funds holding ARWR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Integral Health Asset Management's ARWR Position: Q1 2026 in Review

Integral Health Asset Management increased its Arrowhead Research (ARWR) stake by 200% in Q1 2026, buying an estimated $12.7M and bringing the position to 300,000 shares worth $18.8M. The position accounts for 0.9% of the portfolio, ranked #28.

Integral Health Asset Management first reported a position in ARWR in Q4 2020 and has held it in 7 quarters since. 436 funds tracked by Wall St. Rank hold ARWR as of Q1 2026.

Integral Health Asset Management held 300,000 shares of Arrowhead Research worth $18.8M as of Q1 2026.
Integral Health Asset Management bought 200,000 Arrowhead Research shares in Q1 2026, an estimated $12.7M.
Arrowhead Research made up 0.9% of Integral Health Asset Management's portfolio in Q1 2026, its #28 holding.
Integral Health Asset Management first reported a position in Arrowhead Research in Q4 2020 and has held it in 7 quarters since.
436 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.